ClinicalTrials.Veeva

Menu

Online Tai Chi Plus Fitbit After ACS (Mind2Move)

Beth Israel Lahey Health logo

Beth Israel Lahey Health

Status and phase

Active, not recruiting
Phase 2

Conditions

Physical Inactivity
Acute Coronary Syndrome

Treatments

Behavioral: Tai chi + wearable

Study type

Interventional

Funder types

Other

Identifiers

NCT05699642
2022P000891

Details and patient eligibility

About

This projects studies the role of tai chi exercise and wearable fitness trackers to promote physical activity in acute coronary syndrome (ACS) survivors.

Full description

This is a two-site randomized controlled trial taking place at Beth Israel Deaconess Medical Center in Boston, MA and The Miriam Hospital in Providence, RI. Seventy (n=70) physically inactive ACS survivors will be randomized to either a 6-month group tai chi program (remotely-delivered classes on Zoom) integrated with a wearable self-monitoring/feedback device plus enhanced usual care (EUC), or to EUC alone. EUC will include usual care provided by participants' providers integrated with printed CHD risk factor education materials. Assessments will be conducted in-person at baseline, 6 months (end of treatment), and 9 months. Our primary outcomes will be focused on study feasibility and acceptability. Secondary outcomes include the following patient-centered outcomes: objectively measured (via accelerometry) moderate-vigorous physical activity, light physical activity, sedentary time, cognitive-behavioral constructs (exercise self-efficacy, intrinsic motivation, depression, stress, HRQL), and cardiometabolic measures (exercise capacity, body weight, lipid profile, blood pressure, fasting plasma glucose).

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. History of ACS (unstable angina, NSTEMI, and STEMI, defined per current AHA/ACC criteria);
  2. Age ≥ 18;
  3. Being physically inactive (i.e., < 150 min/week of moderate-intensity aerobic PA);
  4. Absence of contraindications to physical exercise per the participant's provider evaluation;
  5. Access to a digital device with internet connection;
  6. Having an active email account and ability to check email at least weekly;
  7. Physician clearance to participate in low-moderate intensity exercise (tai chi), including a statement that there is no contraindication to exercise based on post-ACS stress test and other factors, as appropriate;
  8. English speaking

Exclusion criteria

  1. Inability or unwillingness to give informed consent;
  2. Blood pressure >200/110 or orthostatic systolic blood pressure decrease >20 mmHg at the baseline visit;
  3. Uncontrolled/untreated atrial or ventricular arrhythmias or 3rd degree AV block;
  4. Within 3 months of a diagnosis of pericarditis or myocarditis;
  5. Medical conditions likely to limit lifespan to less than one year;
  6. New York Heart Association (NYHA) functional class IV;
  7. Severe cognitive impairment (BOMC >10);139
  8. Orthopedic problems prohibiting TC practice;
  9. Ongoing TC or other mind-body training (i.e., meditation, TC, or yoga) at least weekly;
  10. Current enrollment in cardiac rehabilitation;
  11. Untreated severe depression (PHQ>=20);
  12. Conditions likely to affect study compliance (i.e., moving out of study area, substance use, ongoing untreated psychosis);
  13. Symptoms of unstable cardiovascular disease (e.g., shortness of breath or chest pain at rest and/or Canadian Cardiovascular Society Angina Class III-IV)

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

70 participants in 2 patient groups

Tai chi + wearable
Experimental group
Description:
48 virtual tai chi classes on Zoom over 6 months plus assigned home practice of tai chi 3x a week plus daily use of a Fitbit fitness tracker will be required for this group.
Treatment:
Behavioral: Tai chi + wearable
Enhanced usual care
No Intervention group
Description:
Printed educational materials based on existing resources (e.g., AHA; Centers for Disease Control and Prevention) will be shared with subjects in this group.

Trial contacts and locations

1

Loading...

Central trial contact

Daniel Litrownik, BA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems